Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CLINUVEL EUROPE LIMITED

Home Clinical Trial Sponsors and OrganizationsCLINUVEL EUROPE LIMITED

CLINUVEL EUROPE LIMITED

10 EARLSFORT TERRACE, Dublin 2, Ireland

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

15

6 active

Approvals

3

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

8

53.3%

Phase 2

7

46.7%

Trial Status Distribution

Active, not recruiting

6

40.0%

Completed

4

26.7%

Recruiting

4

26.7%

Withdrawn

1

6.7%

Clinical Trials

Trials sponsored by this organization (15)

A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients with Early Parkinson's Disease

Active, not recruiting

Mar 20246 participants

Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients

Mar 202428 participants

A Mechanistic Study to Evaluate Impact of Afamelanotide in Aqueous Solution on Ultraviolet Radiation-Induced DNA Damage and DNA Repair Capacity in Healthy Volunteers

Active, not recruiting

Nov 202310 participants

A Study to Evaluate the Pharmacokinetics of Afamelanotide in Patients with Erythropoietic Protoporphyria (EPP).

Oct 202334 participants

A Phase IIa, Open Label Study to Evaluate the Safety of Afamelanotide in Patients with Early Parkinson's Disease

Active, not recruiting

Apr 202310 participants

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

Mar 20226 participants

Study to evaluate the safety and the efficacy of the photoprotective drug, afamelanotide in patients with Xeroderma Pigmentosum C and V

Active, not recruiting

Nov 20216 participants

Study to evaluate the safety and efficacy of the photoprotective drug, afamelanotide in patients with Xeroderma Pigmentosum C and V

Active, not recruiting

Nov 20216 participants

Page 1 of 2

Approvals

Approvals by Agency

EMA

European Medicines Agency

3

Approvals

Recent Approvals

News

No news articles found

On this page

Overview
Clinical Trials15
Approvals3
News

Back to Organizations